BIOPOR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The firm specializes in coagulation, immunodeficiency, diabetes, peptide hormones, and kidney diseases. Its portfolio consists of NGAL Test, NGAL ELISA kits, MBL ELISA kits, and Antibody Shop. The company was founded on November 22, 1917 and is headquartered in Hellerup, Denmark.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BIOPOR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company